Sirt6 suppresses hepatocellular carcinoma cell growth via inhibiting the extracellular signal-regulated kinase signaling pathway

Molecular Medicine Reports

Volumn 9, Issue 3, 2014, Pages 882-888

  Zhang, Zhi Gao ^a   Qin, Cheng Yong ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Extracellular signal regulated kinase 1 2; Hepatocellular carcinoma; Reactive oxygen species; Sirt6

Indexed keywords

APOPTOSIS; BUTADIENES; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL PROLIFERATION; DOWN-REGULATION; HEK293 CELLS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIRTUINS;

EID: 84893861526     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1879     Document Type: Article

References (36)

1. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
3. Bosch FX, Ribes J, Díaz M and Cléries R: Primary liver cancer: worldwide incidence and trends. Gastroenterology 127 (5 Suppl 1): S5-S16, 2004.
4. Moradpour D, Penin F and Rice CM: Replication of hepatitis C virus. Nat Rev Microbiol 5: 453-463, 2007.
5. Yang JD and Roberts LR: Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 7, 448-458, 2010.
6. Kozyreva ON, Chi D, Clark JW, et al: A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma. Oncologist 16: 310-318, 2011.
7. Haigis MC and Guarente LP: Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev 20: 2913-2921, 2006.
8. Liu T, Liu PY and Marshall GM: The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res 69: 1702-1705, 2009.
9. Alhazzazi TY, Kamarajan P, Verdin E and Kapila YL: SIRT3 and cancer: tumor promoter or suppressor? Biochim Biophys Acta 1816: 80-88, 2011.
10. Hirschey MD, Shimazu T, Goetzman E, et al: SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464: 121-125, 2010.
11. Finley LW, Carracedo A, Lee J, et al: SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell 19: 416-428, 2011.
12. Alhazzazi TY, Kamarajan P, Joo N, et al: Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer 117: 1670-1678, 2011.
13. Zhang YY and Zhou LM: Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation. Biochem Biophys Res Commun 423: 26-31, 2012.
14. Zhong L, D'Urso A, Toiber D, et al: The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 140: 280-293, 2010.
15. Mao Z, Hine C, Tian X, et al: SIRT6 promotes DNA repair under stress by activating PARP1. Science 332: 1443-1446, 2011.
16. Kaidi A, Weinert BT, Choudhary C and Jackson SP: Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 329: 1348-1353, 2010.
17. Min L, Ji Y, Bakiri L, et al: Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat Cell Biol 14: 1203-1211, 2012.
18. Sebastián C, Zwaans BM, Silberman DM, et al: The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151: 1185-1199, 2012.
19. Bauer I, Grozio A, Lasigliè D, et al: The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. J Biol Chem 287: 40924-40937, 2012.
20. Khongkow M, Olmos Y, Gong C, et al: SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer. Carcinogenesis 34: 1476-1486, 2013.
21. Wang P, Guan YF, Du H, Zhai QW, Su DF and Miao CY: Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia. Autophagy 8: 77-87, 2012.
22. Filippi BM, Yang CS, Tang C and Lam TK: Insulin activates Erk1/2 signaling in the dorsal vagal complex to inhibit glucose production. Cell Metab 16: 500-510, 2012.
23. Wang P, Xu TY, Guan YF, Su DF, Fan GR and Miao CY: Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res 81: 370-380, 2009.
24. Nezis IP, Shravage BV, Sagona AP, Johansen T, Baehrecke EH and Stenmark H: Autophagy as a trigger for cell death: autophagic degradation of inhibitor of apoptosis dBruce controls DNA fragmentation during late oogenesis in Drosophila. Autophagy 6: 1214-1215, 2010.
25. Wang P, Tian WW, Song J, Guan YF and Miao CY: Deficiency of NG2+ cells contributes to the susceptibility of stroke-prone spontaneously hypertensive rats. CNS Neurosci Ther 17: 327-332, 2011.
26. Wang P, Xu TY, Guan YF, et al: Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway. Ann Neurol 69: 360-374, 2011.
27. Wang P, Yang FJ, Du H, et al: Involvement of leptin receptor long isoform (LepRb)-STAT3 signaling pathway in brain fat mass-and obesity-associated (FTO) downregulation during energy restriction. Mol Med 17: 523-532, 2011.
28. Wang P, Zhang RY, Song J, et al: Loss of AMP-activated protein kinase-α2 impairs the insulin-sensitizing effect of calorie restriction in skeletal muscle. Diabetes 61: 1051-1061, 2012.
29. Devarajan A, Grijalva VR, Bourquard N, et al: Macrophage paraoxonase 2 regulates calcium homeostasis and cell survival under endoplasmic reticulum stress conditions and is sufficient to prevent the development of aggravated atherosclerosis in paraoxonase 2 deficiency/apoE-/-mice on a Western diet. Mol Genet Metab 107: 416-427, 2012.
30. Colas E, Perez C, Cabrera S, et al: Molecular markers of endometrial carcinoma detected in uterine aspirates. Int J Cancer 129: 2435-2444, 2011.
31. Lai CC, Lin PM, Lin SF, et al: Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumour Biol 34: 1847-1854, 2013.
32. Van Meter M, Mao Z, Gorbunova V and Seluanov A: SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells. Cell Cycle 10: 3153-3158, 2011.
33. Nishimoto S and Nishida E: MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 7: 782-786, 2006.
34. Wiesenauer CA, Yip-Schneider MT, Wang Y and Schmidt CM: Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma. J Am Coll Surg 198: 410-421, 2004.
35. Li Y, Xu W, McBurney MW and Longo VD: SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab 8: 38-48, 2008.
36. Zhao Y, Luo P, Guo Q, et al: Interactions between SIRT1 and MAPK/ERK regulate neuronal apoptosis induced by traumatic brain injury in vitro and in vivo. Exp Neurol 237: 489-498, 2012.